ClinicalTrials.Veeva

Menu

Effect of TECAR on Cervical Radiculopathy

D

Delta University for Science and Technology

Status

Not yet enrolling

Conditions

Cervical Radiculopathy

Treatments

Device: TECAR therapy
Device: Sham TECAR therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT07289607
P.T.REC/012/005936

Details and patient eligibility

About

Cervical radiculopathy is characterized by pain, sensory disturbances, and impaired neuromuscular control due to nerve root compression. Proprioception dysfunction is often an overlooked component of this condition and can affect balance, posture, and motor control.

TECAR (Transfer of Energy Capacitive and Resistive) therapy is a form of deep heat electrotherapy known to improve tissue perfusion and neuromuscular function. Although TECAR is widely used for pain relief and mobility, its role in improving proprioception remains under-investigated, especially in cervical conditions. This study aims to bridge this gap by assessing proprioceptive outcomes in patients with cervical radiculopathy receiving TECAR therapy.

Full description

  • Design: Randomized controlled trial.
  • Groups:
  • Control group: Receives standard physiotherapy (e.g., cervical traction, exercises).
  • Experimental group: Receives TECAR therapy in addition to standard physiotherapy.
  • Duration: 3 sessions per week for 4 weeks.
  • Outcome Measures: Joint position sense (JPS) using cervical repositioning tests, pain (VAS), functional disability (NDI).
  • Assessment Times: Baseline and after 4 weeks.

Enrollment

80 estimated patients

Sex

All

Ages

30 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • • Diagnosed cervical radiculopathy confirmed by clinical and radiological findings

    • Age 30-40 years
    • Pain duration > 4 weeks

Exclusion criteria

  • • Cervical fracture or surgery

    • Vestibular disorders
    • Rheumatologic or neurological diseases
    • Cognitive impairment or pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

80 participants in 2 patient groups

study group
Active Comparator group
Description:
Receives TECAR therapy in addition to standard physiotherapy.
Treatment:
Device: TECAR therapy
Control group
Sham Comparator group
Description:
Receives sham TECAR
Treatment:
Device: Sham TECAR therapy

Trial contacts and locations

1

Loading...

Central trial contact

ibrahim A abu ella, Phd

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems